Rupal Shah, MD, associate professor at the University of California San Francisco, talks about how the onset of the COVID-19 pandemic created an opportunity for patients who have undergone a lung transplant to undergo spirometry testing at home instead of at the the hospital.
The onset of the COVID-19 pandemic generated an opportunity for patients who underwent a lung transplant to use spirometry testing at home instead of in the hospital, says Rupal Shah, MD, associate professor at the University of California San Francisco.
Transcript
Why did you study this topic?
For a long time in lung transplant, we have thought about how to best monitor our patients’ lung function. The way that we monitor how well the transplant is working is with spirometry, which is a test of how well your lungs can take air in and blow it out. Historically, we've had people come to the hospital every 3 months and do the tests in the lab and interpret those results. But it would be much easier if patients, especially those who live far away, could do that at home and could do it more frequently than once every 3 months. So, that was the idea behind trying to get something that we could use at home or remote monitoring.
Obviously, the onset of the pandemic really accelerated that. We were no longer allowed to have people come in for a long time, and then subsequently, everyone needed a COVID-19 test and access was much more limited. Although the concept of remote monitoring existed before the pandemic, I think the onset of the pandemic accelerated the idea of trying to rapidly implement this technology and then study how effective it is and what were the challenges to using it in our population.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More